{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:01:15Z","timestamp":1791216075460,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.neuropharm.2011.08.045","type":"journal-article","created":{"date-parts":[[2011,9,3]],"date-time":"2011-09-03T09:01:12Z","timestamp":1315040472000},"page":"464-473","source":"Crossref","is-referenced-by-count":47,"title":["Pharmacological modulation of stress-induced behavioral changes in the light\/dark exploration test in male C57BL\/6J mice"],"prefix":"10.1016","volume":"62","author":[{"given":"Jessica L.","family":"Ihne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn R.","family":"Hefner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.08.045_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1037\/0735-7044.115.2.443","article-title":"Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: mouse strain-dependent outcomes","volume":"115","author":"Anisman","year":"2001","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib2","doi-asserted-by":"crossref","first-page":"15185","DOI":"10.1523\/JNEUROSCI.2740-10.2010","article-title":"Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun","volume":"30","author":"Baganz","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib3","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/npp.2008.234","article-title":"Enhanced sensitivity of the MRL\/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments","volume":"34","author":"Balu","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-002-1155-6","article-title":"Do animal models of anxiety predict anxiolytic-like effects of antidepressants?","volume":"163","author":"Borsini","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.physbeh.2007.01.024","article-title":"Chronic swim stress alters sensitivity to acute behavioral effects of ethanol in mice","volume":"91","author":"Boyce-Rustay","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib6","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/cercor\/bhp266","article-title":"Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice","volume":"20","author":"Brigman","year":"2010","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s10519-006-9129-9","article-title":"Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT Knockout mice","volume":"37","author":"Carroll","year":"2007","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/appi.ajp.2010.09101452","article-title":"Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits","volume":"167","author":"Caspi","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1126\/science.1129663","article-title":"Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior","volume":"314","author":"Chen","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0091-3057(81)90007-1","article-title":"Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines","volume":"15","author":"Crawley","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1825","article-title":"The ascent of mouse: advances in modelling human depression and anxiety","volume":"4","author":"Cryan","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuron.2009.04.017","article-title":"Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety\/depression","volume":"62","author":"David","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib13","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1300433","article-title":"Effects of chronic fluoxetine in animal models of anxiety and depression","volume":"29","author":"Dulawa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.nbd.2010.08.005","article-title":"Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder?","volume":"40","author":"Fitzgerald","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib15","doi-asserted-by":"crossref","first-page":"13208","DOI":"10.1073\/pnas.0605180103","article-title":"Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects","volume":"103","author":"Govindarajan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib16","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1523\/JNEUROSCI.4904-07.2008","article-title":"Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain","volume":"28","author":"Hefner","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.npp.1301399","article-title":"Behavioral effects of chronic fluoxetine in BALB\/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor","volume":"33","author":"Holick","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0149-7634(01)00012-4","article-title":"Targeted gene mutation approaches to the study of anxiety-like behavior in mice","volume":"25","author":"Holmes","year":"2001","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1601-1848.2003.00052.x","article-title":"The serotonin transporter gene-linked polymorphism and negative emotionality: placing single gene effects in the context of genetic background and environment","volume":"2","author":"Holmes","year":"2003","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0166-4328(01)00184-X","article-title":"Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light\/dark exploration test","volume":"122","author":"Holmes","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib21","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.neubiorev.2005.04.012","article-title":"Early life genetic, epigenetic and environmental factors shaping emotionality in rodents","volume":"29","author":"Holmes","year":"2005","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-9384(00)00373-5","article-title":"Behavioral profile of wild mice in the elevated plus-maze test for anxiety","volume":"71","author":"Holmes","year":"2000","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib23","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neubiorev.2008.11.005","article-title":"Stress-induced prefrontal reorganization and executive dysfunction in rodents","volume":"33","author":"Holmes","year":"2009","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib24","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.psyneuen.2008.07.010","article-title":"Multifaceted strain-specific effects in a mouse model of depression and of antidepressant reversal","volume":"33","author":"Ibarguen-Vargas","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib25","doi-asserted-by":"crossref","first-page":"e10404","DOI":"10.1371\/journal.pone.0010404","article-title":"Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice","volume":"5","author":"Isingrini","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10519-006-9106-3","article-title":"Feeling strained? Influence of genetic background on depression-related behavior in mice: a review","volume":"37","author":"Jacobson","year":"2007","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00213-007-0945-2","article-title":"The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice","volume":"195","author":"Karlsson","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib28","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.biopsych.2008.05.001","article-title":"Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2\/3 agonist","volume":"64","author":"Karlsson","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1176\/appi.ajp.161.4.631","article-title":"The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression","volume":"161","author":"Kendler","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cell.2007.09.018","article-title":"Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions","volume":"131","author":"Krishnan","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pbb.2008.01.014","article-title":"Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice","volume":"90","author":"Mathiasen","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbr.2006.07.029","article-title":"Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice","volume":"175","author":"Mineur","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1017\/S1461145709990630","article-title":"Differential effects of acute and repeated citalopram in mouse models of anxiety and depression","volume":"13","author":"Mombereau","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib34","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1523\/JNEUROSCI.5017-09.2010","article-title":"Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitability","volume":"30","author":"Mozhui","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00213-008-1215-7","article-title":"Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL\/6J or BALB\/cJ mice","volume":"200","author":"Norcross","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib36","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/npp.2009.47","article-title":"Paradoxical anxiogenic response of juvenile mice to fluoxetine","volume":"34","author":"Oh","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib37","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbr.2004.04.008","article-title":"Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress","volume":"155","author":"Pothion","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib39","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn1944","article-title":"Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic","volume":"10","author":"Ressler","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.neuron.2009.12.003","article-title":"5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants","volume":"65","author":"Richardson-Jones","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1034\/j.1601-183X.2002.10406.x","article-title":"Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline","volume":"1","author":"Rodgers","year":"2002","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib42","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10802-008-9256-2","article-title":"Biological implications of gene-environment interaction","volume":"36","author":"Rutter","year":"2008","journal-title":"J.\u00a0Abnorm Child. Psychol."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib43","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/mp.2008.20","article-title":"Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania","volume":"13","author":"Shaltiel","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib44","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/cercor\/bhp003","article-title":"Stress-induced dendritic remodeling in the prefrontal cortex is circuit specific","volume":"19","author":"Shansky","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib45","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/sj.npp.1300532","article-title":"Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration","volume":"29","author":"Strekalova","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib46","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/npp.2008.76","article-title":"Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal","volume":"34","author":"Surget","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02244948","article-title":"Differences in fear motivated behaviors among inbred mouse strains","volume":"111","author":"Trullas","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuron.2010.12.023","article-title":"Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events","volume":"69","author":"Uchida","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib49","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1523\/JNEUROSCI.22-15-06810.2002","article-title":"Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons","volume":"22","author":"Vyas","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib50","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.mp.4002056","article-title":"Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and \u2018schizophrenia-related\u2019 behaviors","volume":"13","author":"Wiedholz","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002130050456","article-title":"Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation","volume":"134","author":"Willner","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0031-9384(95)02256-2","article-title":"Decreased hedonic responsiveness following chronic mild stress is not secondary to loss of body weight","volume":"60","author":"Willner","year":"1996","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbr.2008.04.021","article-title":"Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey","volume":"193","author":"Yalcin","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.08.045_bib54","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1038\/sj.npp.1301665","article-title":"Variation in mouse basolateral amygdala volume is associated with differences in stress reactivity and fear learning","volume":"33","author":"Yang","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.08.045_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2007.09.006","article-title":"Response variation following trauma: a translational neuroscience approach to understanding PTSD","volume":"56","author":"Yehuda","year":"2007","journal-title":"Neuron"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811003789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811003789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T22:25:25Z","timestamp":1560551125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811003789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0028390811003789"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.08.045","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}